Torrent Pharmaceuticals Limited · NSE: TORNTPHARM · BSE: 500420
Torrent Pharmaceuticals
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 30 Jul 2026.
Q1 FY27 · Consolidated
Revenue
4,921.00₹ Cr
+54.8% vs year ago
Net profit
566.00₹ Cr
+3.3% vs year ago
EPS, basic
14.87₹
−8.2% vs year ago
Net margin
11.5%
−5.7 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 4,921.00 | +54.8% | 566.00 | +3.3% | 14.87 | 30 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 4,197.00 | +41.8% | 364.00 | −26.9% | 11.51 | 23 May 2026 |
| Q3 FY26Oct–Dec 2025 | 3,303.00 | +17.6% | 635.00 | +26.2% | 18.77 | 13 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 3,302.00 | +14.3% | 591.00 | +30.5% | 17.45 | 07 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 3,178.00 | +11.2% | 548.00 | +19.9% | 16.19 | 28 Jul 2025 |
| Q4 FY25Jan–Mar 2025 | 2,959.00 | +7.8% | 498.00 | +10.9% | 14.71 | 21 May 2025 |
| Q3 FY25Oct–Dec 2024 | 2,809.00 | +2.8% | 503.00 | +13.5% | 14.88 | 24 Jan 2025 |
| Q2 FY25Jul–Sep 2024 | 2,889.00 | +8.6% | 453.00 | +17.4% | 13.37 | 28 Oct 2024 |
| Q1 FY25Apr–Jun 2024 | 2,859.00 | +10.3% | 457.00 | +20.9% | 13.51 | 24 Jul 2024 |
| Q4 FY24Jan–Mar 2024 | 2,745.00 | +10.2% | 449.00 | +56.4% | 13.27 | 25 May 2024 |
| Q3 FY24Oct–Dec 2023 | 2,732.00 | +9.7% | 443.00 | +56.5% | 13.10 | 02 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 2,660.00 | +16.1% | 386.00 | +23.7% | 11.39 | 25 Oct 2023 |
| Q1 FY24Apr–Jun 2023 | 2,591.00 | +10.4% | 378.00 | +6.8% | 11.18 | 07 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 2,491.00 | +16.9% | 287.00 | Turned profit | 8.48 | 30 May 2023 |
| Q3 FY23Oct–Dec 2022 | 2,491.00 | +18.2% | 283.00 | +13.7% | 8.36 | 27 Jan 2023 |
| Q2 FY23Jul–Sep 2022 | 2,291.00 | +7.2% | 312.00 | −1.3% | 9.22 | 24 Oct 2022 |
| Q1 FY23Apr–Jun 2022 | 2,347.00 | +10.0% | 354.00 | +7.3% | 20.90 | 30 Jul 2022 |
| Q4 FY22Jan–Mar 2022 | 2,131.00 | +10.0% | (118.00) | Turned loss | (6.98) | 26 May 2022 |
| Q3 FY22Oct–Dec 2021 | 2,108.00 | +5.7% | 249.00 | −16.2% | 14.75 | 25 Jan 2022 |
| Q2 FY22Jul–Sep 2021 | 2,137.00 | +5.9% | 316.00 | +1.9% | 18.63 | 27 Oct 2021 |
| Q1 FY22Apr–Jun 2021 | 2,134.00 | +3.8% | 330.00 | +2.8% | 19.53 | 27 Jul 2021 |
| Q4 FY21Jan–Mar 2021 | 1,937.00 | −0.5% | 324.00 | +3.2% | 19.16 | 18 May 2021 |
| Q3 FY21Oct–Dec 2020 | 1,995.00 | +1.5% | 297.00 | +18.3% | 17.52 | 08 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 2,017.00 | +0.6% | 310.00 | +27.0% | 18.32 | 26 Oct 2020 |
| Q1 FY21Apr–Jun 2020 | 2,056.00 | +1.7% | 321.00 | +48.6% | 18.98 | 31 Jul 2020 |
| Q4 FY20Jan–Mar 2020 | 1,946.00 | +4.8% | 314.00 | Turned profit | 18.56 | 27 May 2020 |
| Q3 FY20Oct–Dec 2019 | 1,966.00 | −4.1% | 251.00 | +2.0% | 14.77 | 28 Jan 2020 |
| Q2 FY20Jul–Sep 2019 | 2,005.00 | +5.9% | 244.00 | +36.3% | 14.48 | 24 Oct 2019 |
| Q1 FY20Apr–Jun 2019 | 2,022.00 | +8.0% | 216.00 | +32.5% | 12.74 | 24 Jul 2019 |
| Q4 FY19Jan–Mar 2019 | 1,856.00 | — | (152.00) | — | (8.95) | 21 May 2019 |
| Q3 FY19Oct–Dec 2018 | 2,051.00 | — | 246.00 | — | 14.50 | 30 Jan 2019 |
| Q2 FY19Jul–Sep 2018 | 1,894.00 | — | 179.00 | — | 10.57 | 04 Nov 2018 |
| Q1 FY19Apr–Jun 2018 | 1,872.00 | — | 163.00 | — | 9.66 | 03 Aug 2018 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 4,158.00 | +58.9% | 492.00 | −10.7% | 12.94 | 30 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 2,735.00 | +12.4% | 467.00 | −1.5% | 13.80 | 23 May 2026 |
| Q3 FY26Oct–Dec 2025 | 2,599.00 | +9.3% | 577.00 | +19.0% | 17.04 | 13 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 2,762.00 | +13.5% | 597.00 | +29.8% | 17.64 | 07 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 2,616.00 | +7.3% | 551.00 | +17.5% | 16.28 | 28 Jul 2025 |
| Q4 FY25Jan–Mar 2025 | 2,433.00 | +13.5% | 474.00 | +15.6% | 14.00 | 21 May 2025 |
| Q3 FY25Oct–Dec 2024 | 2,377.00 | +12.0% | 485.00 | +63.3% | 14.33 | 24 Jan 2025 |
| Q2 FY25Jul–Sep 2024 | 2,434.00 | +13.4% | 460.00 | +40.7% | 13.60 | 28 Oct 2024 |
| Q1 FY25Apr–Jun 2024 | 2,438.00 | +14.9% | 469.00 | +45.2% | 13.86 | 24 Jul 2024 |
| Q4 FY24Jan–Mar 2024 | 2,143.00 | +11.6% | 410.00 | +87.2% | 12.12 | 25 May 2024 |
| Q3 FY24Oct–Dec 2023 | 2,123.00 | +14.3% | 297.00 | +29.7% | 8.78 | 02 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 2,146.00 | +11.3% | 327.00 | +20.2% | 9.65 | 25 Oct 2023 |
| Q1 FY24Apr–Jun 2023 | 2,121.00 | +9.7% | 323.00 | −1.2% | 9.55 | 07 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 1,920.00 | +15.5% | 219.00 | −0.9% | 6.46 | 30 May 2023 |
| Q3 FY23Oct–Dec 2022 | 1,857.00 | +16.9% | 229.00 | +34.7% | 6.78 | 27 Jan 2023 |
| Q2 FY23Jul–Sep 2022 | 1,928.00 | +7.2% | 272.00 | −16.6% | 8.02 | 24 Oct 2022 |
| Q1 FY23Apr–Jun 2022 | 1,933.00 | +14.0% | 327.00 | +19.3% | 19.35 | 30 Jul 2022 |
| Q4 FY22Jan–Mar 2022 | 1,662.00 | +13.2% | 221.00 | −20.8% | 13.08 | 26 May 2022 |
| Q3 FY22Oct–Dec 2021 | 1,588.00 | −1.7% | 170.00 | −38.8% | 10.06 | 25 Jan 2022 |
| Q2 FY22Jul–Sep 2021 | 1,799.00 | +9.7% | 326.00 | +15.2% | 19.24 | 27 Oct 2021 |
| Q1 FY22Apr–Jun 2021 | 1,695.00 | −1.9% | 274.00 | −8.1% | 16.21 | 27 Jul 2021 |
| Q4 FY21Jan–Mar 2021 | 1,468.00 | −1.5% | 279.00 | +66.1% | 16.48 | 18 May 2021 |
| Q3 FY21Oct–Dec 2020 | 1,616.00 | +9.9% | 278.00 | +26.4% | 16.45 | 08 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 1,640.00 | +2.3% | 283.00 | −13.7% | 16.68 | 26 Oct 2020 |
| Q1 FY21Apr–Jun 2020 | 1,727.00 | +7.7% | 298.00 | +33.6% | 17.63 | 31 Jul 2020 |
| Q4 FY20Jan–Mar 2020 | 1,491.00 | +9.9% | 168.00 | +2.4% | 9.91 | 27 May 2020 |
| Q3 FY20Oct–Dec 2019 | 1,471.00 | −0.7% | 220.00 | +20.9% | 12.97 | 28 Jan 2020 |
| Q2 FY20Jul–Sep 2019 | 1,603.00 | +8.9% | 328.00 | +18.4% | 19.40 | 24 Oct 2019 |
| Q1 FY20Apr–Jun 2019 | 1,603.00 | +10.4% | 223.00 | +82.8% | 13.18 | 24 Jul 2019 |
| Q4 FY19Jan–Mar 2019 | 1,357.00 | — | 164.00 | — | 9.73 | 21 May 2019 |
| Q3 FY19Oct–Dec 2018 | 1,481.00 | — | 182.00 | — | 10.73 | 30 Jan 2019 |
| Q2 FY19Jul–Sep 2018 | 1,472.00 | — | 277.00 | — | 16.38 | 04 Nov 2018 |
| Q1 FY19Apr–Jun 2018 | 1,452.00 | — | 122.00 | — | 7.21 | 03 Aug 2018 |
66 filings on record for this company.